BIOMAT Database Logo BIOMAT Database Logo

Measles and rubella immunisation campaign. Safety untested. 1994

R Stephenson

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D008457 Measles A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM. Rubeola
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012409 Rubella An acute infectious disease caused by the RUBELLA VIRUS. The virus enters the respiratory tract via airborne droplet and spreads to the LYMPHATIC SYSTEM. Measles, German,Three Day Measles,German Measles,Measle, Three Day,Measles, Three Day,Rubellas,Three Day Measle
D012411 Rubella Vaccine A live attenuated virus vaccine of duck embryo or human diploid cell tissue culture origin, used for routine immunization of children and for immunization of nonpregnant adolescent and adult females of childbearing age who are unimmunized and do not have serum antibodies to rubella. Children are usually immunized with measles-mumps-rubella combination vaccine. (Dorland, 28th ed) Vaccine, Rubella

Related Publications

R Stephenson
National measles and rubella immunisation campaign.
August 1994, Communicable disease report. CDR weekly,
R Stephenson
The measles/rubella immunisation campaign in Scotland.
January 1996, Health bulletin,
R Stephenson
Measles and rubella immunisation campaign. Is a booster necessary?
October 1994, BMJ (Clinical research ed.),
R Stephenson
Measles and rubella immunisation campaign. May have medicolegal consequences.
October 1994, BMJ (Clinical research ed.),
R Stephenson
Measles and rubella immunisation campaign. Older children should be included.
October 1994, BMJ (Clinical research ed.),
R Stephenson
Measles and rubella immunisation.
April 1995, BMJ (Clinical research ed.),
R Stephenson
Measles, mumps, and rubella immunisation.
January 1989, Lancet (London, England),
R Stephenson
Information for all doctors. Update of success of measles/rubella immunisation campaign.
September 1995, Health bulletin,
R Stephenson
The Measles/Rubella Immunisation Campaign in Greater Glasgow: a success in collaboration.
May 1996, Health bulletin,
R Stephenson
[Measles-rubella vaccination campaign].
January 1984, L'Infirmiere francaise,
Copied contents to your clipboard!